Publications by authors named "Charles Pippitt"

Claim this Profile
A
A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer.
Ignace Vergote, Russell J Schilder, Charles H Pippitt, Shirley Wong, Alan N Gordon

Gynecol Oncol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancer.
Ignace B Vergote, Agustin Garcia, John Micha, Charles Pippitt, Johanna Bendell

J Clin Oncol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer.
Beth Y Karlan, Amit M Oza, Gary E Richardson, Diane M Provencher, Vincent L Hansen, Charles H Pippitt

J Clin Oncol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of sequential doublets: topotecan and carboplatin, followed by paclitaxel and carboplatin, in patients with newly diagnosed advanced ovarian cancer.
Alan N Gordon, Lina Asmar, Mark J Messing, Daron G Street, Charles H Pippitt

Gynecol Oncol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis